Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Management of Hypotension In Preterm Infants: The HIP Trial Protocol for a Randomized Controlled Trial of Hypotension Management in the Extremely Low Gestational Age Newborn

Trial Profile

Management of Hypotension In Preterm Infants: The HIP Trial Protocol for a Randomized Controlled Trial of Hypotension Management in the Extremely Low Gestational Age Newborn

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 04 Oct 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dopamine (Primary)
  • Indications Hypotension
  • Focus Registrational; Therapeutic Use
  • Acronyms HIP
  • Sponsors BrePco Biopharma
  • Most Recent Events

    • 30 Sep 2019 Status changed from recruiting to discontinued.
    • 25 Jun 2019 According to a BrePco Biopharma media release, this trial is being conducted by a consortium of 13 institutions, mostly university hospitals, from six EU member states and Canada. The HIP trial was funded in part by a European Union FP7 grant.
    • 25 Jun 2019 According to a BrePco Biopharma media release, interim results from the trial were reported at the Paediatric Academic Societies annual meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top